SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (18619)4/4/1998 11:47:00 PM
From: Flagrante Delictu  Respond to of 32384
 
Henry, OFF TOPIC Great news. Hope the girls have another thrilling season.



To: Henry Niman who wrote (18619)4/5/1998 9:52:00 AM
From: Flagrante Delictu  Read Replies (6) | Respond to of 32384
 
Henry, ON TOPIC This morning, NBC news is reporting that as a result of a 6 year test, Tamoxifen has been shown to be the first agent to show proof of breast cancer prevention. We believe that LGND's Targretin is an even better prevention agent, though it has yet to complete enough testing to gain the same recognition.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News